Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 2056 AL 2070

P-tau217 as a Biomarker in Alzheimer's Disease: Applications in Latin American Populations

Varela-Vidales CA, Martínez-Hernández A, Hernández-Castellanos E, Delgado-Lara DLC.

Int J Mol Sci. 2025 Jul 10;26(14):6633. doi: 10.3390/ijms26146633.

Diabetes affects AD through plasma Aβ40: A Mendelian randomization study

Yang Q, Huang D, Zhang Z, Gao H, Wu J, Zhong H, Guo X, Wang Y, Zhou H, Liu C, Duan X.

Neuroscience. 2025 May 24;575:131-139. doi: 10.1016/j.neuroscience.2025.04.025. Epub 2025 Apr 13.

Atypical Alzheimer's dementia: Addressing the subtypes, epidemiology, atypical presentations, diagnostic biomarkers, and treatment updates

Vora N, Patel P, Marsool MDM, Marsool ADM, Sunasra R, Ladani P, Pati S, Khoont D, Prajjwal P, Ranjan R.

Dis Mon. 2025 May;71(5):101863. doi: 10.1016/j.disamonth.2025.101863. Epub 2025 Feb 1.

Complementary utility of plasma biomarkers and Aβ-PET for diagnosis, risk-stratification, and treatment monitoring in Alzheimer's disease

Collij LE, Mattsson-Carlgren N, Janelidze S, Ossenkoppele R, Hansson O.

Alzheimers Dement. 2025 Oct;21(10):e70763. doi: 10.1002/alz.70763.

Comparison of plasma p-tau217/Aβ42, p-tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease

Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown C, Tropea TF, Lee EB, Tosun D, Landau SM, Okonkwo OC, Mindt MR, Weiner MW, Irwin DJ, Wolk DA, Shaw LM; and the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Aug;21(8):e70469. doi: 10.1002/alz.70469.

Multimorbidity and fluid biomarkers of Alzheimer's disease: a systematic review

Valletta M, Canevelli M, Gasparini F, Buscarnera S, Salzillo M, Triolo F, Calderón-Larrañaga A, Marengoni A, Vetrano DL, Grande G.

Eur Geriatr Med. 2025 Aug;16(4):1121-1136. doi: 10.1007/s41999-025-01222-y. Epub 2025 May 20.

Spotlight on Alzheimer's disease and related dementias research in East Asia

Le W, Shen L, Guo T, Xie F.

Alzheimers Dement. 2025 Jul;21(7):e70479. doi: 10.1002/alz.70479.

Comprehensive evaluation of plasma tau biomarkers for detecting and monitoring Alzheimer's disease in a multicenter and multiethnic aging population

Lan G, Wang M, Gonzalez-Ortiz F, Zhang L, Li A, Li B, Jiang M, Yang J, Chen X, Shi D, Fan X, Cai Y, Sun P, Liu L, Li J, He Z, Fang L, Zhou X, Chen L, Wang Y, Li M, Liu Z, Wang Q, Xu L, Zhou L, Cheng G, Wang X, Ran P, Wang L, Sun K, Han Y, Guan Y, Blennow K, Xie F, Guo T.

Nat Aging. 2025 Aug;5(8):1601-1618. doi: 10.1038/s43587-025-00904-3. Epub 2025 Jun 23.

Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology

Rafii MS, Schlachetzki Z, Barroeta I, Head E, Fortea J, Ances BM.

Lancet Neurol. 2025 Sep;24(9):753-762. doi: 10.1016/S1474-4422(25)00237-6.

Prevalence of Alzheimer's disease pathology in the community

Aarsland D, Sunde AL, Tovar-Rios DA, Leuzy A, Fladby T, Zetterberg H, Blennow K, Tan K, De Santis G, Yakoub Y, Arslan B, Huber H, Pola I, Grötschel L, Di Molfetta G, Skjellegrind HK, Selbaek G, Ashton NJ.

Nature. 2026 Feb;650(8100):182-186. doi: 10.1038/s41586-025-09841-y. Epub 2025 Dec 17.

Alzheimer disease seen through the lens of sex and gender

Castro-Aldrete L, Einsiedler M, Novakova Martinkova J, Depypere H, Alvin Ang TF, Mielke MM, Sindi S, Eyre HA, Au R, Schumacher Dimech AM, Dé A, Szoeke C, Tartaglia MC, Santuccione Chadha A.

Nat Rev Neurol. 2025 May;21(5):235-249. doi: 10.1038/s41582-025-01071-0. Epub 2025 Apr 14.

Sleep disorders increase the risk of dementia, Alzheimer's disease, and cognitive decline: a meta-analysis

Ungvari Z, Fekete M, Lehoczki A, Munkácsy G, Fekete JT, Zábó V, Purebl G, Varga P, Ungvari A, Győrffy B.

Geroscience. 2025 Jun;47(3):4899-4920. doi: 10.1007/s11357-025-01637-2. Epub 2025 Apr 11.

Pathogenesis of comorbid epilepsy in Alzheimer's disease and use of perampanel, an AMPA receptor inhibitor

Kuzuya A, Ohara T, Akamatsu N.

Expert Rev Neurother. 2025 Dec;25(12):1399-1409. doi: 10.1080/14737175.2025.2581758. Epub 2025 Oct 30.

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records

Hamieh N, Ansart M, Guinebretiere O, Lekens B, Gantzer L, Durrleman S, Nedelec T.

J Affect Disord. 2025 Aug 1;382:148-153. doi: 10.1016/j.jad.2025.04.094. Epub 2025 Apr 20.

Viral infections and the risk of neurodegenerative diseases: a comprehensive meta-analysis and systematic review

Liu RY, Yin KF, He SY, Su WM, Duan QQ, Wen XJ, Chen T, Shen C, Li JR, Cao B, Chen YP.

Transl Psychiatry. 2025 Oct 10;15(1):388. doi: 10.1038/s41398-025-03639-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias